FindTrial
Sign In

Study of malaria pathogen and drug response

Host mediated regulation of Invasion, Egress and Drug response of Plasmodium falciparum and Plasmodium vivax Malaria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020521
Enrollment
1050
Registered
2019-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B948- Sequelae of other specified infectious and parasitic diseases

Interventions

None listed

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case: Participants aged between 5-70 years infected with Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) malaria are included in this study. Control: Participants aged between 5-70 years who never had any Plasmodium infection and hailing from the same endemic area are included as control participants.

Exclusion criteria

Exclusion criteria: Case: Participants under the age of 5 and above 70 are excluded from the study. Other exclusion criteria include pregnant women, participants undergone treatment for malaria for past 3 months Control: Pregnant women and participants with other clinical conditions are excluded from the study.

Design outcomes

Primary

MeasureTime frame
Identification of genetic variationsTimepoint: First, second and third year—

Secondary

MeasureTime frame
Identification of markers of malaria resistance/susceptibilityTimepoint: Third year—

Countries

India

Contacts

Public ContactDr TGVasudevan

Manipal School of Life Sciences, MAHE, Manipal

saadiabdulvahab@gmail.com9448984726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026